Announced Fri, 23 May · 18:50 IST

submission of Audited standalone Financial Results for the Quarter and financial year ended March, 31 2025

Pat NegativeDebt Equity ThresholdResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Chemiesynth (Vapi) Ltd reported audited results for FY25 with revenue from operations rising to Rs 1,888.71 lakhs from Rs 1,643.35 lakhs in FY24, a growth of about 15%. Q4 FY25 revenue was strong at Rs 668.45 lakhs versus Rs 445.26 lakhs in Q4 FY24. Despite revenue growth, the company posted a loss after tax of Rs 10.62 lakhs in FY25, though the loss narrowed sharply from Rs 38.82 lakhs in FY24. Q4 FY25 turned profitable with a PAT of Rs 18.86 lakhs versus a loss of Rs 20.12 lakhs in the year-ago quarter. Operating cash flow improved significantly to Rs 264.76 lakhs in FY25 from negative Rs 2.57 lakhs in FY24. Statutory auditor M/s Manoj Shah & Co issued an unmodified (clean) opinion on the results.

Likely market impact

For shareholders: FY25 losses narrowed considerably and Q4 swung to profit, showing operational improvement. However, the full-year bottom line remained negative and total borrowings of ~Rs 1,502 lakhs against equity of ~Rs 1,098 lakhs indicate a high debt burden (D/E ~1.37x), which remains a watchpoint despite the improved operating cash flows.